RENAL FAILURE 2019, VOL. 41, NO. 1, 69–71 https://doi.org/10.1080/0886022X.2019.1573499 EDITORIAL Medicine, Division of Nephrology and Ralph H. Johnson VA Medical Center and serving as Medical Director for Dialysis Units in the community and at the VA Medical Center. Earlier in my carrier, I have served on the faculty of several prestigious institutions, including the University of Mississippi, the University of Iowa, the University of Debrecen and the Semmelweis University in Hungary. Over the last 2 years our Publisher, Taylor & Francis Online, and the dedicated personnel of the Editorial Office, have overseen the transition to an Open Access (OA) model of publishing and a dramatic increase of downloads for the Journal worldwide with an improved overall aca- demic impact. OA publishing, while initially viewed with disdain by some of us, is now embracing ‘mainstream’ publications, increasingly becoming the norm of academic publishing. The success of journals such as PLoS One and Scientific Reports bears testimony to this transition. An increasing number of authors are now encouraged or required to publish OA by their funding bodies, institu- tions, or their employers. To that end, our Publisher will also offer significant support for authors from countries with lesser financial means: corresponding authors with primary affiliations in countries defined by the World Bank as ‘Low-Income Economies’ can apply for a 100% article processing change (APC) waiver; those from ‘Lower-Middle Income Economies’ can apply for a 50% APC discount. Additionally, corresponding authors with primary affilia- tions based in one of the EIFL (Electronic Information for Libraries) network countries may be eligible for a 100% or 50% discount as well. Dear Readers and Nephrology Colleagues, Over the last couple of years, we have seen the Journal publish highly impactful papers on a wealth of issues, As of January 1, 2019, I had the distinct privilege to including meta-analyses on the link between proton-pump assume the position of the new Editor-in-Chief for the inhibitors and hypomagnesemia , on the impact of over- journal Renal Failure. First of all, I would like to thank the hydrated status and low lean tissue in end-stage renal dis- previous Chief Editor, Dr. William F. Finn, for his years of ease (ESRD) patients , on uric acid lowering therapy and dedicated work. Such transition will take place at a tumul- chronic kidney disease progression  and a systemic review tuous time in academic publishing, but I hope to use this and meta-analysis further confirming cinacalcet’slack of challenge as an opportunity to raise the Journal to the impact on survival in (ESRD) patients . Single-center stud- next level of academic exchange of information. ies published in the Journal have explored the impact of AKI Introducing myself, I am Board Certified Nephrologist and in donors on renal graft survival subsequent to renal trans- Internist and licensed to practice in both Mississippi and plantation , the risk of AKI after transcatheter aortic valve South Caroline (U.S.), as well as in the European Union placement  and quality of life, as well as the correlation of (Hungary). Currently, I am a Full Professor of Medicine at personality profiles and coping styles with clinical outcomes the Medical University of South Carolina (MUSC) and in ESRD patients on maintenance hemodialysis . Attending Physician for the MUSC’s Department of Additional publications in the Journal have also explored the 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 70 EDITORIAL frequency and clinical characteristics of invasive fungal infec- science is sound, even if certain questions might remain tions in renal transplant recipients , the value of combin- unanswered in the study. ation biomarkers in predicting renal impairment after a Our impact factor is currently standing at 1.44 and we cardiovascular bypass procedure , the clinical characteris- look forward to attracting exciting papers on a wealth of tics of sepsis-induced AKI from China , post-partum renal issues but focus predominantly on AKI and aspects of crit- injury from India  outcomes and characteristics of AKI in ical care nephrology [17,28,29]. None of us went into hospitalized patients from sub-Saharan Africa. Emerging Medicine hoping to find a boring job, and academic writ- technologies, such as bioimpedance spectroscopy-assisted ing – so it seems to so many of us – is akin to a child’s volume status assessment also received prominent attention birth: it is immensely joyous and exhilarating to bring in the Journal over this period [2,12]. Along with human something into this world, which never existed before. The studies, the Journal has published important works on ani- future is ours to make it better and I hope to find fellow mal models of AKI as well. These have included work on the travelers on this road. Let’s make it happen! potential protective role of N-acetylcysteine in oxalate- induced AKI in a rat model , the protective effect of ber- References berine against gentamycin-induced nephrotoxicity in rats  and its possible underlying mechanisms, and explored  Cheungpasitporn W, Thongprayoon C, Kittanamongkolchai W, theprotective roleof heme oxygenase-1 on thecourse of Srivali N, Edmonds PJ, Ungprasert P, et al. Proton pump inhibitors linked to hypomagnesemia: a systematic review cisplatin-induced nephrotoxicity . and meta-analysis of observational studies. Ren Fail. 2015; Nephrology in the acute care setting is moving into an 37(7):1237–1241. era of cooperation and interaction between several disci-  Hwang SD, Lee JH, Lee SW, Kim JK, Kim M-J, Song JH. Risk of plines to address the complex needs stemming from the overhydration and low lean tissue index as measured using a patients’ multi-faceted problems. We should remember body composition monitor in patients on hemodialysis: a sys- that in most settings, renal replacement therapy in the temic review and meta-analysis. Ren Fail. 2018;40(1):51–59.  Liu X, Zhai T, Ma R, Luo C, Wang H, Liu L. Effects of uric acid- Intensive Care Units is still associated with at least 50% in lowering therapy on the progression of chronic kidney dis- mortality rate [10,16–18] – obviously, the current status ease: a systematic review and meta-analysis. Ren Fail. 2018; quo of practice (and knowledge) is insufficient and the 40(1):289–297. one thing that cannot be justified is inertia. To mention  Sekercioglu N, Busse JW, Sekercioglu MF, Agarwal A, Shaikh just a few examples, there is exciting literature emerging S, Lopes LC, et al. Cinacalcet versus standard treatment for on fluid overload and volume determination in critically ill chronic kidney disease: a systematic review and meta-ana- lysis. Ren Fail. 2016;38(6):857–874. patients with acute kidney injury (AKI) [19–22], the impact  Zheng YT, Chen CB, Yuan XP, Wang CX. Impact of acute kid- of other organ failures (liver, heart) in AKI , on periton- ney injury in donors on renal graft survival: a systematic eal dialysis as a viable alternative for continuous renal review and Meta-Analysis. Ren Fail. 2018;40(1):649–656. replacement therapy [24,25] and on the uniqueness of  Thongprayoon C, Cheungpasitporn W, Srivali N, Harrison AM, medication dosing in those with critical illness receiving Kittanamongkolchai W, Greason KL, et al. Transapical versus transfemoral approach and risk of acute kidney injury follow- renal replacement therapy [26,27]. All these issues will ing transcatheter aortic valve replacement: a propensity- likely expand in the future and attract a global readership. adjusted analysis. Ren Fail. 2017;39(1):13–18. To stay relevant in the globally connected world, it is  D’Onofrio G, Simeoni M, Rizza P, Caroleo M, Capria M, important to have a global representation and reverbera- Mazzitello G, et al. Quality of life, clinical outcome, personal- tions of our publications. In my role as Editor-in-Chief, ity and coping in chronic hemodialysis patients. Ren Fail. I will look forward to identifying talented and motivated 2017;39(1):45–53.  Patel MH, Patel RD, Vanikar AV, Kanodia KV, Suthar KS, Nigam young clinician-scientists to assist us with the onerous LK, et al. Invasive fungal infections in renal transplant work of peer reviews and to seeing them on our Editorial patients: a single center study. Ren Fail. 2017;39(1):294–298. Board (EB) as the Journal grows. We will strongly seek to  Prowle JR, Calzavacca P, Licari E, Ligabo EV, Echeverri JE, develop a pool of peer reviewers and EB members who Bagshaw SM, et al. Combination of biomarkers for diagnosis are reflecting, in composition and interest, the Journal’s of acute kidney injury after cardiopulmonary bypass. Ren Fail. 2015;37(3):408–416. international readership. As an added benefit, our publica-  Shum H-P, Kong HH-Y, Chan K-C, Yan W-W, Chan TM. Septic tion fee is already substantially reduced for the EB mem- acute kidney injury in critically ill patients–a single-center bers. We also sincerely hope the next generation of young study on its incidence, clinical characteristics, and outcome clinician-scientists will find it worthy not only to read the predictors. Ren Fail. 2016;38(5):706–716. Journal but also to publish with us. We look forward to fur-  Eswarappa M, Madhyastha PR, Puri S, Varma V, Bhandari A, ther attracting a vibrant and international readership who Chennabassappa G. Postpartum acute kidney injury: a review of 99 cases. Ren Fail. 2016;38(6):889–893. are likely to return to the journal’s website after their initial  Rymarz A, Gibinska J, Zajbt M, Piechota W, Niemczyk S. Low positive experiences. There is great competition going on lean tissue mass can be a predictor of one-year survival in in the modern world to attract quality papers and readers. hemodialysis patients. Ren Fail. 2018;40(1):231–237. Those who read papers are the most likely to organize  Shimizu MH, Gois PH, Volpini RA, Canale D, Luchi WM, their own studies and publish new ones. We will strongly Froeder L, et al. N-acetylcysteine protects against star fruit- consider the publication of novel ideas if the underlying induced acute kidney injury. Ren Fail. 2017;39(1):193–202. RENAL FAILURE 71  Adil M, Kandhare AD, Dalvi G, Ghosh P, Venkata S, Raygude Multicentre Investigation on Fluid Assessment (DoReMIFA) in KS, et al. Ameliorative effect of berberine against gentamicin- critically ill patients. Crit Care. 2016;20(1):196. induced nephrotoxicity in rats via attenuation of oxidative  Ponce D, Goes C, Oliveira M, Balbi A. Peritoneal Dialysis for stress, inflammation, apoptosis and mitochondrial dysfunc- the Treatment of Cardiorenal Syndrome Type 1: A tion. Ren Fail. 2016;38(6):996–1006. Prospective Brazilian Study. Perit Dial Int. 2017;37(5):578–583.  Behiry S, Rabie A, Kora M, Ismail W, Sabry D, Zahran A. Effect  Ponce D, Buffarah MB, Goes C, Balbi A. Peritoneal Dialysis in of combination sildenafil and gemfibrozil on cisplatin-induced Acute Kidney Injury: Trends in the Outcome across Time nephrotoxicity; role of heme oxygenase-1. Ren Fail. 2018; Periods. PLoS One. 2015;10(5):e0126436. 40(1):371–378.  Ful € op € T, Zsom L, Tapolyai MB, Molnar MZ, Rosivall L. Volume-  Brar H, Olivier J, Lebrun C, Gabbard W, Fulop T, Schmidt D. related weight gain as an independent indication for renal Predictors of mortality in a cohort of intensive care unit replacement therapy in the intensive care units. J Renal Inj patients with acute renal failure receiving continuous renal Prev. 2017;6(1):35–42. replacement therapy. Am J Med Sci. 2008;335(5):342–347.  Ponce D, Zamoner W, Freitas FM, Balbi A, Awdishu L.  Wu L, Zhang P, Yang Y, Jiang H, He Y, Xu C, et al. Long-term Vancomycin Removal During High-Volume Peritoneal Dialysis renal and overall survival of critically ill patients with acute in Acute Kidney Injury Patients: A Prospective Cohort Clinical renal injury who received continuous renal replacement ther- Study. Kidney Int Rep. 2019;4(1):112–118. apy. Ren Fail. 2017;39(1):736–744.  Eyler RF, Mueller BA, Medscape. Antibiotic dosing in critically  Cho AY, Yoon HJ, Lee KY, Sun IO. Clinical characteristics of ill patients with acute kidney injury. Nat Rev Nephrol. 2011; sepsis-induced acute kidney injury in patients undergoing 7(4):226–235. continuous renal replacement therapy. Renal failure. 2018;  Cho AY, Yoon HJ, Lee KY, Sun IO. Clinical characteristics of 40(1):403–409. € #1; sepsis-induced acute kidney injury in patients undergoing  Ful € op T, Pathak MB, Schmidt DW, Lengvarszky Z, Juncos JP, Lebrun CJ, et al. Volume-related weight gain and subsequent continuous renal replacement therapy. Ren Fail. 2018;40(1): mortality in acute renal failure patients treated with continu- 403–409. ous renal replacement therapy. ASAIO J. 2010;56(4):333.  Gameiro J, Goncalves M, Pereira M, Rodrigues N, Godinho I,  Chen H, Wu B, Gong D, Liu Z. Fluid overload at start of con- Neves M, et al. Obesity, acute kidney injury and mortality in tinuous renal replacement therapy is associated with poorer patients with sepsis: a cohort analysis. Ren Fail. 2018;40(1): clinical condition and outcome: a prospective observational 120–126. study on the combined use of bioimpedance vector analysis and serum N-terminal pro-B-type natriuretic peptide meas- Respectfully, urement. Crit Care. 2015;19(1):135. Tibor Ful € op, € M.D., Ph.D.  Vaara ST, Korhonen A-M, Kaukonen K-M, Nisula S, Inkinen O, Hoppu S, et al. Fluid overload is associated with an increased Professor of Medicine risk for 90-day mortality in critically ill patients with renal Department of Medicine, Division of Nephrology, replacement therapy: data from the prospective FINNAKI Medical University of South Carolina, study. Crit Care. 2012;16(5):R197. Charleston, SC, USA  Garzotto F, Ostermann M, Martin-Langerwerf D, Sanchez- Sanchez M, Teng J, Robert R, et al. The Dose Response firstname.lastname@example.org
Renal Failure – Pubmed Central
Published: Feb 12, 2019
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera